Metraipolis › archive › dc_b0f76b5908cb
Pan-cancer molecular signatures connecting aspartate transaminase to cancer prognosis, metabolic and immune signatures — Europe PMC PMID:42245720
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42245720
- DOI
- 10.3389/fonc.2026.1727389
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-01T13:10:47.543Z
- SHA-256 of the archived text
bf8c345e168d2f038ca80fd76c99b92b6ba20d9aaec1fa16d4ad533c4cb21b23- Stable URL of this page
https://metraipolis.com/documento/dc_b0f76b5908cb
How to cite
Pan-cancer molecular signatures connecting aspartate transaminase to cancer prognosis, metabolic and immune signatures — Europe PMC PMID:42245720 — Europe PMC (en), https://europepmc.org/article/MED/42245720 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b0f76b5908cb (Metraipolis archive dc_b0f76b5908cb, sha256 bf8c345e168d2f038ca80fd76c99b92b6ba20d9aaec1fa16d4ad533c4cb21b23)
BibTeX
@misc{dcb0f76b5908cb,
title = {Pan-cancer molecular signatures connecting aspartate transaminase to cancer prognosis, metabolic and immune signatures — Europe PMC PMID:42245720},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42245720},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b0f76b5908cb; sha256 bf8c345e168d2f038ca80fd76c99b92b6ba20d9aaec1fa16d4ad533c4cb21b23},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42245720. Agents can read the archived copy with the MCP tool read_document.